Click here for Xalkori® (crizotinib) Prescribing Information. Adverse event reporting information can be found at the bottom of the page.
Should we be reflex-ROS1 testing on ALL lung cancer patients? Professor Nicholson gives his professional opinion on this question and others, including tips for laboratories who want to validate their own ROS1 testing service.
Professor Andrew Nicholson is a Diagnostic Thoracic Pathologist at the Royal Brompton Hospital in London, where he conducts research into thoracic cancers, including lung cancer, mesothelioma and thymic tumours. He is a past Chair of the International Association for the Study of Lung Cancer (IASLC) Pathology Panel, as well as a member of the IASLC Staging and Prognostic Factors Committee. He is also an honorary Professor of Respiratory Pathology at Imperial College London.
XALKORI as a monotherapy is indicated for:1
Stay up to date with the latest relevant healthcare, medical and promotional information about medicines and vaccines promoted by Pfizer.
PP-PFE-GBR-2809. March 2021
Sign up now
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-PFE-GBR-2688. December 2020